VIE/ABC (VIE/ABC)

Vienna Stock Exchange: VIE/ABC · EUR

€294

+1.50 (+0.5%)· Recorded snapshot

Market cap	55.8B
Revenue (ttm)	291.3B
Net income (ttm)	2.3B
EPS (ttm)	€12.1
P/E (trailing)	24.3x
P/E (forward)	16.8x
Dividend	€2.06 (0.70%)
Volume	5

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 291.3B
Net income (ttm): 2.3B
EPS (ttm): €12.1
P/E (trailing): 24.3x
P/E (forward): 16.8x
Market cap: 55.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/E24.3

P25 n/aP50 n/aP75 n/a

ROE96.9

P25 n/aP50 n/aP75 n/a

ROIC20.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/ABC indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

USD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-04
Employees	49,000
Employees change	5,000
Employees growth	10.87%
Enterprise value	EUR 66.4B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	1871
Industry	Medical Distribution
Is primary listing	No
ISIN number	US03073E1055
Last earnings date	2026-08-05
Last refreshed	2026-10-29
Market cap	EUR 55.8B
Next earnings date	2026-11-04
Price	EUR 293.80
Price currency	EUR
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-29
Symbol	vie/ABC
Website	https://www.cencora.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.13x
Average P/E ratio (3Y)	28.29x
Average P/E ratio (5Y)	24.33x
Earnings yield	4.11%
EV/Earnings	28.79x
EV/EBIT	16.41x
EV/EBITDA	12.42x
EV/FCF	18.61x
EV/Sales	0.22x
FCF / EV yield	5.37%
FCF yield	6.4%
Forward P/E	16.81x
Graham number	63.72249
Graham upside	-78.2%
Lynch fair value	EUR 191.31
Lynch upside	-34.55%
P/(FCF - SBC) ratio	16.22x
P/(OCF - SBC) ratio	13.58x
P/B ratio	19.59x
P/E ratio	24.31x
P/FCF ratio	15.63x
P/OCF ratio	13.16x
P/S ratio	0.19x
Price/EBITDA ratio	11.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.35%
EBITDA margin	1.67%
Effective tax rate	26.82%
FCF margin	1.19%
Gross margin	3.96%
Operating margin	1.35%
Pretax margin	1.08%
Profit margin	0.79%
Profit per employee	EUR 46,887
Profitable quarters	3
Profitable years	5
Revenue per employee	EUR 5.9M
ROA	3.56%
ROA (5Y)	2.99%
ROCE	18.25%
ROE	96.87%
ROIC	20.95%
ROIC (5Y)	47.06%
SBC / revenue	0.04%
Tax / revenue	0.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	39.11%
EPS growth (Q)	11.93%
EPS growth (QoQ)	-53.1%
EPS growth 10Y	6.18%
EPS growth 3Y	18.02%
EPS growth quarters	3
EPS growth years	1
FCF growth	255.65%
FCF growth (QoQ)	106.99%
FCF growth 3Y	13.29%
FCF growth 5Y	9.63%
Gross profit growth	22.92%
Gross profit growth (Q)	24.3%
Gross profit growth 3Y	15.64%
Gross profit growth 5Y	16.8%
Net income growth	38.35%
Net income growth (Q)	11.07%
Net income growth (QoQ)	-53.48%
Net income growth 3Y	15.82%
Net income growth quarters	3
Net income growth years	1
OCF growth	176.74%
OCF growth (Q)	2,329.41%
OCF growth (QoQ)	98.27%
OCF growth 10Y	4.91%
OCF growth 3Y	14.06%
OCF growth 5Y	10.28%
Operating income growth	30.32%
Operating income growth (Q)	23.65%
Operating income growth 3Y	22.48%
Operating income growth 5Y	11.75%
Revenue growth	5.09%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	8.17%
Revenue growth 10Y	8.68%
Revenue growth 3Y	9.36%
Revenue growth 5Y	10.25%
Revenue growth quarters	56
Revenue growth years	13

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -666M
Depreciation and amortization	EUR 946.9M
EBIT	EUR 3.9B
EBITDA	EUR 4.9B
EPS	EUR 12.08
Financing cash flow	EUR 1.4B
Free cash flow	EUR 3.6B
Free cash flow minus SBC	EUR 3.4B
Gross profit	EUR 11.5B
Income taxes	EUR 846.7M
Investing cash flow	EUR -5B
Net borrowing	EUR 2.8B
Net cash flow	EUR 516.1M
Net income	EUR 2.3B
Operating cash flow minus SBC	EUR 4.1B
Operating income	EUR 3.9B
Revenue	EUR 291.3B
Stock-based compensation	EUR 130.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.7
Book value per share	EUR 13.99
Debt / EBITDA	2.44
Debt / equity	4.47
Debt / FCF	3.56
Goodwill	EUR 14.8B
Interest coverage	8.78
Long-term assets	EUR 23.7B
Long-term liabilities	EUR 17.4B
Net cash (debt)	EUR -10.2B
Net cash / market cap	-18.36%
Net debt / EBITDA	2.1
Net debt / equity	3.6
Net debt / FCF	2.87
Piotroski F-Score	6
Property, plant and equipment	EUR 2.5B
Shareholders' equity	EUR 2.8B
Tangible book value	EUR -17B
Tangible book value per share	EUR -88.96
Total assets	EUR 73.4B
Total cash	EUR 2.5B
Total debt	EUR 12.7B
Total liabilities	EUR 70.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	4.22
Current assets	EUR 49.7B
Current liabilities	EUR 53.1B
Current ratio	0.93
Inventory turnover	15.53
Net working capital	EUR -5.2B
Quick ratio	0.48
Working capital	EUR -3.4B
Working capital turnover	-64.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.46%
Dividend growth	2.23%
Dividend growth (3Y)	4.3%
Dividend growth years	3
Dividend payment date	2026-08-31
Dividend payment years	5
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.06
Dividend yield	0.7%
Ex-dividend date	2026-08-14
Last dividend	EUR 0.52
Payout ratio	17.83%
Shareholder yield	1.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 265.07
1D price change	0.51%
1M price change	9.63%
1M total return	9.63%
1W price change	-2.72%
1W total return	-2.72%
1Y price change	1.82%
1Y return CAGR	2.59%
1Y total return	2.59%
20-day SMA	EUR 292.34
200-day SMA	EUR 274.26
3M price change	5.61%
3M total return	5.81%
3Y price change	65.13%
3Y return CAGR	19.18%
3Y total return	69.29%
50-day SMA	EUR 283.24
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 330.40
52-week high date	2025-11-26
52-week low	EUR 214.30
52-week low date	2026-05-07
6M price change	10.2%
6M total return	10.67%
All-time high	EUR 330.40
All-time high date	2025-11-26
All-time low	EUR 138.98
All-time low date	2023-03-13
Average true range (ATR)	EUR 4.99
Average volume	4.1
Change from 52-week high	-11.08%
Change from 52-week low	37.1%
Change from all-time high	-11.08%
Change from all-time low	111.4%
Change from open	1.17%
Day's gap	-0.65%
Dollar volume	EUR 1,469
High price	EUR 294.50
Low price	EUR 290.40
Monthly RSI	59.1
Open price	EUR 290.40
Position in 52-week range	82.93%
Previous close	EUR 292.30
Price vs 150-day SMA	10.84%
Price vs 20-day SMA	0.5%
Price vs 200-day SMA	7.12%
Price vs 50-day SMA	3.73%
Relative volume	1.32
RSI	53.92
Sharpe ratio	0.16
Sharpe ratio (3Y)	0.66
Sortino ratio	0.38
Sortino ratio (3Y)	1.12
Volume	5
Weekly RSI	58.36
YTD price change	1.66%
YTD total return	2.26%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	180.3M
Shares change (QoQ)	-0.74%
Shares change (YoY)	-0.46%
Shares held by insiders	0.38%
Shares held by institutions	97.16%
Short ratio	3 days

Deeper analysis on VIE/ABC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ABC report

Is a complete VIE/ABC research report available?

No complete published report is available for vie/ABC (VIE/ABC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ABC (VIE/ABC)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ABC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/ABC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ABC

Frequently asked questions